Curia Completes Acquisition of LakePharma
2021-09-02Category: Announcement
Curia
Completes Acquisition of LakePharma
Adds biologics
development capabilities, expertise and scale from discovery through GMP
manufacturing
Albany,
NY – September 2, 2021 – Curia, formerly AMRI, a leading contract research, development
and manufacturing organization, today announced it has completed the transaction to acquire LakePharma
Inc., a privately held biologics drug discovery, clinical research, development
and manufacturing organization with operations in California, Massachusetts and
Texas. With the addition of LakePharma, Curia offers deep expertise in both
large and small molecules from drug discovery through drug substance
manufacturing, sterile injectable formulation and fill-finish production.
“The completion
of LakePharma transforms our biologics offering, enabling us to provide
end-to-end capabilities to customers, based on deep scientific expertise and an
integrated technology platform,” said Curia Chairman and CEO John Ratliff. “Together
with Integrity Bio, now part of Curia, this transaction represents a major
milestone in our growth journey and means we can deliver seamless solutions and
expanded capacity for biologics customers. I’m delighted to welcome our new
colleagues from LakePharma to the global Curia community and to work with them
to advance our customers from curiosity to cure.”
LakePharma
will operate as part of Curia’s Research and Development division, led by
Christopher Conway, president, R&D. Hua Tu, Ph.D., LakePharma’s founder and
CEO, also will serve on Curia’s executive team as chief technology officer. LakePharma
and its “The Biologics Company” brand will migrate to the Curia brand in the
future. It will continue to use its name for an interim period, adding “Now
part of Curia” to its logo.
About Curia
Curia, formerly AMRI, is a leading
contract research, development and manufacturing organization providing
products and services from R&D through commercial manufacturing to pharmaceutical
and biopharmaceutical customers. Curia’s more than 3,700 employees at 29
locations across the U.S., Europe and Asia help its customers advance from
curiosity to cure. Learn more at CuriaGlobal.com.
|
Corporate Contact: |
Media Communications: |
|
Sue Zaranek |
Debra Harrsch |
|
Curia |
Brandwidth Solutions LLC |
|
+1 518 512 2111 |
+1 215 997 8575 |
